MAPT and Alzheimer disease: Falls are correlated with biomarkers of neurodegenerative disease, including hippocampal volume,[65] and genetic risk is tightly intertwined with pathways contributing to tau and β-amyloid aggregation, particularly in the hippocampus, and especially in early AD.[66] Therefore, falls should be more intentionally monitored in individuals at high genetic risk of dementia.